EP3116547

Meðferðar-nanóagnir sem innihalda meðferðarmiðil og aðferðir til framleiðslu og notkunar á þeim

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    13.3.2015
  • EP published:
    5.6.2019
  • EP application number:
    15713285.3
  • Max expiry date:
    12.3.2035
  • Expiry date:
    12.3.2022
  • Title:
    THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME

Timeline

Today
13.3.2015EP application
5.6.2019EP Publication
1.7.2019Translation submitted
15.7.2019Registration published
12.3.2022Expires

Owner

  • Name:
    Pfizer Inc.
  • Address:
    235 East 42nd Street, 10017, New York, NY, US

Inventor

  • Name:
    BAGRODIA, Shubha
  • Address:
    San Diego, CA, US
  • Name:
    LAFONTAINE, Jennifer
  • Address:
    San Diego, CA, US
  • Name:
    LOVATT, Zach
  • Address:
    Danvers, MA, US
  • Name:
    SHIN, Eyoung
  • Address:
    Marlborough, MA, US
  • Name:
    SONG, Young, Ho
  • Address:
    Natick, MA, US
  • Name:
    TROIANO, Greg
  • Address:
    Pembroke, MA, US
  • Name:
    WANG, Hong
  • Address:
    Newton, MA, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201461953628 P
  • Date:
    14.3.2014
  • Country:
    US

Classification

  • Categories:
    A61K 47/12, A61K 47/28, A61K 47/34, A61K 9/107, A61K 9/51, A61K 31/5377

Annual fees

Number

Paid

Expires

Payer

Number: 6

Paid: 3.1.2020

Expires: 12.3.2021

Payer: Árnason Faktor ehf.

Number: 7

Paid: 10.2.2021

Expires: 12.3.2022

Payer: Örn Þór slf.

Upload documents